Atlas Trials

Transurethral Resection of Bladder Tumor (TURBT) Combined With Adjuvant Intravenous GC Chemotherapy for Non-muscle-invasive Bladder Cancer

Clinical trial NCT02716961 · UNKNOWN

Trial details

NCT number
NCT02716961
Sponsor
The First Affiliated Hospital with Nanjing Medical University
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Bladder CancerGemcitabine and Cisplatin ChemotherapyEpirubicin InstillationRecurrencePrognosis
Start date
2016-01-01
Primary completion
2020-12-01
Enrollment
208

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.